✦ LIBER ✦

24 Phase III study of gemcitabine (Gemzar®) versus best supportive care (BSC) in advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Anderson, H.; Cottier, B.; Nicolson, M.; Milroy, R.; Maughan, T.; Bond, M.; Falk, S.; Burt, P.; Carmichael, J.; Thatcher, N.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Taxotere® (TXT) versus best supportive c

✍ K. Roszkowski 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 161 KB

A data-based meta-analysis of randomised

✍ Souhami, R.L.; Stewart, L.A.; Arriagada, R.; Parmar, M.; Le Chevalier, T.; Pigno 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 112 KB

84P MAINTENANCE LOW-DOSE GEMCITABINE VER

✍ Nagy, A.A.; Fouad, E.; Nasr, K.; El-Ghazaly, H.; Adel, A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB

PCN42 POOLING CLINICAL AND COST OUTCOMES

✍ R McAllister; D Meddis; J Jansen; J Ryan; J Brown 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Vinorelbine (VNR) plus best supportive c

✍ Gridelli, C; Ianniello, GP; Maiorino, L; Brancaccio, L; Cigolari, S; Bilancia, D 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Relationship between quality of life and

✍ Thongprasert, S 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 79 KB